Digestive Diseases and Sciences

, Volume 49, Issue 11–12, pp 1758–1762 | Cite as

Serum Angiogenin in Inflammatory Bowel Disease

  • Ioannis E. KoutroubakisEmail author
  • Costas Xidakis
  • Konstantinos Karmiris
  • Aekaterini Sfiridaki
  • Ermioni Kandidaki
  • Elias A. Kouroumalis


Angiogenesis-promoting cytokines have been suggested to play an important role in inflammatory bowel disease (IBD) since they promote inflammation by increasing vascular permeability and mediate tissue repair by activating fibroblasts. The aim of the present study was to evaluate the serum levels of angiogenin, a potent angiogenic factor, in patients with ulcerative colitis (UC) and Crohn’s disease (CD). Angiogenin serum levels were measured in 154 IBD patients (78 UC and 76 CD), in 18 cases with other causes of intestinal inflammation, and in 84 matched healthy controls using a commercially available enzyme-linked immunosorbent assay. Angiogenin levels were assessed in terms of disease activity, type, localization, and treatment. Mean (±SD) serum angiogenin levels were 526.5 ± 224.1 ng/ml in UC patients, 508.8 ± 228.5 ng/ml in CD patients, 394.6 ± 137.6 ng/ml in healthy controls, and 448.1 ± 167.8 ng/ml in patients with non-IBD intestinal inflammation. A statistically significant difference among the mean levels of angiogenin in the four groups was found (P=0.0003). IBD patients with early disease had a significantly lower mean serum angiogenin compared with patients with late disease (P=0.03). No significant association between angiogenin levels and disease activity, localization, disease type, or treatment was found. Serum angiogenin is elevated in patients with IBD. The increased serum angiogenin suggests that angiogenin may mediate angiogenesis and vascular permeability in the mucosa of patients with IBD.

angiogenesis angiogenin Crohn’s disease ulcerative colitis-7 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Srivastava M, Zurakowski D, Cheifetz P, Leichtner A, Bousvaros A: Elevated serum hepatocyte growth factor in children and young adults with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 33:548–553, 2001CrossRefPubMedGoogle Scholar
  2. 2.
    Kanazawa S, Tsunoda T, Onuma E, Majima T, Kagiyama M, Kikuchi K: VEGF, basic FGF, and TGF-beta in Crohn’s disease and ulcerative colitis: A novel mechanism of chronic intestinal inflammation. Am J Gastroenterol 96:822–828, 2001PubMedGoogle Scholar
  3. 3.
    Bousvaros A, Zurakowski D, Fishman SJ, Keough K, Law T, Sun C, Leichtner AM: Serum basic fibroblast growth factor in pediatric Crohn’s disease. Implications for wound healing. Dig Dis Sci 42:378–386, 1997CrossRefPubMedGoogle Scholar
  4. 4.
    Bousvaros A, Leichtner A, Zurakowski D, Kwon J, Law T, Keough K, Fishman S: Elevated serum vascular endothelial growth factor in children and young adults with Crohn’s disease. Dig Dis Sci 44:424–430, 1999CrossRefPubMedGoogle Scholar
  5. 5.
    Griga T, Tromm A, Spranger J, May B: Increased serum levels of vascular endothelial growth factor in patients with inflammatory bowel disease. Scand J Gastroenterol 33:504–508, 1998CrossRefPubMedGoogle Scholar
  6. 6.
    Badet J: Angiogenin, a potent mediator of angiogenesis: Biological, biochemical and structural properties. Pathol Biol 47:345–351, 1999PubMedGoogle Scholar
  7. 7.
    Shapiro R, Riordan JF, Vallee BL: Characteristic ribonucleolytic activity of human angiogenin. Biochemistry 25:3527–3532, 1986CrossRefGoogle Scholar
  8. 8.
    Strydom DJ: The angiogenins. Cell Mol Life Sci 54(8):811–824, 1998CrossRefPubMedGoogle Scholar
  9. 9.
    King TV, Vallee BL: Neovascularisation of the meniscus with angiogenin. An experimental study in rabbits. J Bone Joint Surg (Br) 73-B:587–590, 1991CrossRefGoogle Scholar
  10. 10.
    Soncin F, Guitton JD, Cartwright T, Badet J: Interaction of human angiogenin with copper modulates angiogenin binding to endothelial cells. Biochem Biophys Res Commun 236:604–610, 1997CrossRefPubMedGoogle Scholar
  11. 11.
    Olson KA, Verselis SJ, Fett JW: Angiogenin is regulated in vivo as an acute phase protein. Biochem Biophys Res Commun 242:480–483, 1998CrossRefPubMedGoogle Scholar
  12. 12.
    Verselis SJ, Olson KA, Fett JW: Regulation of angiogenin expression in human HepG2 hepatoma cells by mediators of the acute-phase response. Biochem Biophys Res Commun 259:178–184, 1999CrossRefPubMedGoogle Scholar
  13. 13.
    Sheen-Chen SM, Eng HL, Chen WJ, Chou FF, Chen HS: Serum level of angiogenin in breast cancer. Anticancer Res 20:4769–4771, 2000PubMedGoogle Scholar
  14. 14.
    Ugurel S, Rappl G, Tilgen W, Reinhold U: Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival. J Clin Oncol 19:577–583, 2001CrossRefPubMedGoogle Scholar
  15. 15.
    Brunner B, Gunsilius E, Schumacher P, Zwierzina H, Gastl G, Stauder R: Blood levels of angiogenin and vascular endothelial growth factor are elevated in myelodysplastic syndromes and in acute myeloid leukemia. J Hematother Stem Cell Res 11:119–125, 2002CrossRefPubMedGoogle Scholar
  16. 16.
    Steff AM, Gagne D, Page M, Rioux A, Hugo P, Gosselin D: Serum concentrations of insulin-like growth factor-1, soluble tumor necrosis factor receptor-1 and angiogenin in endometriosis patients. Am J Reprod Immunol 51:166–173, 2004CrossRefPubMedGoogle Scholar
  17. 17.
    Burgmann H, Hollenstein U, Maca T, Zedwitz-Liebenstein K, Thalhammer F, Koppensteiner R, Ehringer H, Graninger W: Increased serum laminin and angiogenin concentrations in patients with peripheral arterial occlusive disease. J Clin Pathol 49:508–510, 1996CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Chiarelli F, Pomilio M, Mohn A, Tumini S, Verrotti A, Mezzetti A, Cipollone F, Wasniewska M, Morgese G, Spagnoli A: Serum angiogenin concentrations in young patients with diabetes mellitus. Eur J Clin Invest 32:110–114, 2002CrossRefPubMedGoogle Scholar
  19. 19.
    Lennard-Jones JE: Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 24:2–6, 1989CrossRefGoogle Scholar
  20. 20.
    Best WR, Becktel JM, Singleton JW, Kern F Jr: Development of a Crohn’s disease activity index. National Cooperative Crohn’s Disease Study. Gastroenterology 70:439–444, 1976CrossRefPubMedGoogle Scholar
  21. 21.
    Walmsley RS, Ayres RC, Pounder RE, Allan RN: A simple clinical colitis activity index. Gut 43:29–32, 1998CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Liote F, Champy R, Moenner M, Boval-Boizard B, Badet J: Elevated angiogenin levels in synovial fluid from patients with inflammatory arthritis and secretion of angiogenin by cultured synovial fibroblasts. Clin Exp Immunol 132:163–168, 2003CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Distler JH, Hirth A, Kurowska-Stolarska M, Gay RE, Gay S, Distler O: Angiogenic and angiostatic factors in the molecular control of angiogenesis. Q J Nucl Med 47:149–161, 2003PubMedGoogle Scholar
  24. 24.
    Griga T, May B, Pfisterer O, Muller KM, Brasch F: Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease. Hepatogastroenterology 49:116–123, 2002PubMedGoogle Scholar
  25. 25.
    Saito S, Tsuno NH, Sunami E, Hori N, Kitayama J, Kazama S, Okaji Y, Kawai K, Kanazawa T, Watanabe T, Shibata Y, Nagawa H: Expression of platelet-derived endothelial cell growth factor in inflammatory bowel disease. J Gastroenterol 38:229–237, 2003CrossRefPubMedGoogle Scholar
  26. 26.
    Tschesche H, Kopp C, Horl WH, Hempelmann U: Inhibition of degranulation of polymorphonuclear leukocytes by angiogenin and its tryptic fragment. J Biol Chem 269:30274–30280, 1994PubMedGoogle Scholar
  27. 27.
    Schmaldienst S, Oberpichler A, Tschesche H, Horl WH: Angiogenin: A novel inhibitor of neutrophil lactoferrin release during extracorporeal circulation. Kidney Blood Press Res 26:107–112, 2003CrossRefPubMedGoogle Scholar
  28. 28.
    Matousek J, Soucek J, Riha J, Zankel TR, Benner SA: Immunosuppressive activity of angiogenin in comparison with bovine seminal ribonuclease and pancreatic ribonuclease. Comp Biochem Physiol B Biochem Mol Biol 112:235–241, 1995CrossRefPubMedGoogle Scholar
  29. 29.
    Wakefield AJ, Sawyerr AM, Dhillon AP, Pittilo RM, Raules PM, Lewis AAM, Pounder R: Pathogenesis of Crohn’s disease: Multifocal gastrointestinal infarction. Lancet 2:1057–1062, 1989CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2004

Authors and Affiliations

  • Ioannis E. Koutroubakis
    • 1
    Email author
  • Costas Xidakis
    • 1
  • Konstantinos Karmiris
    • 1
  • Aekaterini Sfiridaki
    • 2
  • Ermioni Kandidaki
    • 2
  • Elias A. Kouroumalis
    • 1
  1. 1.Department of GastroenterologyUniversity Hospital HeraklionHeraklionGreece
  2. 2.Regional Blood Bank CenterHeraklionGreece

Personalised recommendations